0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > IGF-II

IGF-II

Brief Information

Name:Insulin-like growth factor II
Target Synonym:T3M-11-derived growth factor,PP1446,IGF2,Insulin-like growth factor II,Insulin Like Growth Factor 2,Preptin,IGF-II,Insulin-Like Growth Factor 2 (Somatomedin A),Chromosome 11 Open Reading Frame 43,Insulin-Like Growth Factor Type 2,Insulin-Like Growth Factor 2,Somatomedin-A,Somatomedin A,C11orf43,PP9974,GRDF,SRS3,FLJ44734
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Par statut du produit :
Par catégorie de produit :
Par espèce :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
IG2-H5143 Human Human IGF-II Protein, His Tag (SPR verified)
IG2-H5143-structure
IG2-H5143-sds
IG2-H82F9 Human Biotinylated Human IGF-II Protein, Avitag™,Fc Tag
IG2-H82F9-structure
IG2-H82F9-sds
IG2-H4260 Human Human IGF-II Protein, Fc Tag
IG2-H4260-structure
IG2-H4260-sds
ACRO Quality

Part of Bioactivity data

IG2-H5143-SPR
 IGF-II SPR

Human IGF-I R / CD221 Protein, His Tag (MALS verified) (Cat. No. IGR-H5229) immobilized on CM5 Chip can bind Human IGF-II Protein, His Tag (Cat. No. IG2-H5143) with an affinity constant of 150 nM as determined in a SPR assay (Biacore 8K) (QC tested).

IG2-H4260-ELISA
 IGF-II ELISA

Immobilized Human IGFBP-3, His Tag (Cat. No. IG3-H52H9) at 0.5 μg/mL (100 μL/well) can bind Human IGF-II, Fc Tag (Cat. No. IG2-H4260) with a linear range of 1.2-39 ng/mL (QC tested).

Synonym Name

IGF2,C11orf43,FLJ22066,FLJ44734,IGF-II,PP9974

Background

Insulin-like growth factor 2 (IGF-2) is also known as Somatomedin-A, IGF-II, PP9974, and is one of three protein hormones  that share structural similarity to insulin. IGF-2 exerts its effects by binding to the IGF-1 receptor. IGF2 may also bind to the IGF-2 receptor (also called the cation-independent mannose 6-phosphate receptor), which acts as a signalling antagonist; that is, to prevent IGF2 responses. The major role of IGF2 is as a growth promoting hormone during gestation. In the process of Folliculogenesis, IGF2 is created by Theca cells to act in an autocrine manner on the theca cells themselves, and in a paracrine manner on Granulosa cells in the ovary. IGF2 promotes granulosa cell proliferation during the follicular phase of the menstrual cycle, acting alongside Follicle Stimulating Hormone (FSH). After ovulation has occurred, IGF-2 promotes progesterone secretion during the luteal phase of the menstrual cycle together with Luteinizing Hormone (LH). Thus, IGF2 acts as a Co-hormone together with both FSH and LH. IGF-2  may play a key role in memory and could potentially be used to treat Alzheimer's Disease. It is sometimes produced in excess in islet cell tumours, causing hypoglycemia. Doege-Potter syndrome is a paraneoplastic syndrome in which hypoglycemia is associated with the presence of one or more non-islet fibrous tumors in the pleural cavity. has been shown to interact with IGFBP3 and Transferrin.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Xentuzumab BI-836845 Phase 2 Clinical C.H. Boehringer Sohn Ag & Co. Kg Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Dusigitumab MEDI-573 Phase 2 Clinical Medimmune Llc Solid tumours; Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular Details

This web search service is supported by Google Inc.

totop

Laisser un message